Fall, 2006 Newsletter
Articles:
Nanotoxicology:
An Emerging Discipline Evolving from Studies of Ultrafine Particles by G.
Obedorster, E. Oberdorster, J. Oberdorster (July 2005) - A comprehensive review
of all aspects of the field of nanotoxicology summarized by S. Shami. At
nanotoxicology2005
New
information on the Single Pass Liquid Aerosol generator is found at:
http://www.inhalation.net/bbg.pdf
(CH Technologies, Inc.)
The Cells of the Lungs, Sergei P. Sorokin, Department
of Anatomy, Harvard Medical School, Boston, Massachusetts. In the
"Morphology of Experimental Respriatory Carcinogenesis". (1970) The
original reference for the statement that there are 40 cell types in the lung.
(Shami and Evans)
Sorokin Review. (In
process)
Our other staff will be submitting topics
for the fall newsletter soon.
The
Spring 2003
newsletter
was distributed
Feb 28, 2003
and topics were:
Catalytic Antioxidant Inhibits Smoke-induced Inflammation in Rat Lung
Gender
and enhanced sensitivity to odors
Pulmonary effects of inhaled
ammonium salts in rat
lungs
Review
of Occupational Respiratory Diseases, 2002
Effect of House Dust Mite Allergen on
Remodeling of basement membrane
Recent Developments in Technology
from your Sponsor, CH Technologies, Inc.:
SPECIAL NOTICE TO INFECTIOUS DISEASE
INVESTIGATORS:
CH Technologies (USA) Inc., in
association with Henri Baumgartner (IDE) of Belmont, Switzerland announces the
immediate availability of a mouse vaccine development exposure system (MoVaDeExSy).
A prototype drawing for a larger rodent system is found at
http://www.toxics.com. The
design is based on 64 port geometry using newly developed mouse tubes for sealed
exposure use.
Units are likely to be severely limited in availability but
investigators interested in working with bio-terrorism agents and respiratory
viruses will be given first preference. The unit is designed to fit in very
small bio-containment facilities.
Flow rates for operation
will be less than 16 liters per minute., The MoVaDeExSy exposure unit will use
either the Vilnius Dry Powder (VAG-2 for an Anthrax model) or the single/triple
jet BioAerosol Nebulizing Generator (BANG) for a SmallPox or SARS disease
model.
Since equipment availability is limited, orders will be
filled on a first request basis.
For more new products see Products
Page
09/20/2006 05:44:43 PM -0500
sshami@sbcglobal.net
